期刊文献+

姜黄素对人正常肝细胞角蛋白1和内质网蛋白19表达的影响 被引量:1

Effects of curcumin on expression of cytokeratin 1 and endoplasmic reticulum protein 19 in human normal hepatocytes
在线阅读 下载PDF
导出
摘要 目的应用双向凝胶电泳、质谱技术和蛋白免疫印迹研究姜黄素(Curcumin,CUR)对人正常肝细胞蛋白质组的影响。方法随机将人正常肝细胞L-02分成两组,对照组不作任何处理,姜黄素组以25μmol.L-1姜黄素处理L-02细胞24 h。用双向凝胶电泳建立姜黄素组和对照组的双向凝胶电泳图谱,并用Image Master 2D Platinum 6.0软件进行差异蛋白质组分析,所获得的明显差异蛋白质用MALDI-TOF-MS进行鉴定分析,最后用蛋白免疫印迹法进行验证。结果姜黄素作用于人正常肝细胞后,有2个蛋白质的表达发生明显变化,角蛋白1与内质网蛋白19表达均上调。结论上调角蛋白1和内质网蛋白19可能是姜黄素抗肿瘤、抗氧化作用的机制之一。 Aim To observe the effects of curcumin (CUR) on human normal hepatocytes proteome by bidimensional gel electrophoresis, mass spectrometry and western blot. Methods The L-02 cells were randomly divided into two groups, control group and CUR group in which the cells were treated with CUR (25 μmol ·L^-1 ) for 24 hours. The bidirectional gel electrophoresis was used to establish the two-dimensional gel electrophoresis patterns of proteome in group of human normal hepatic ceils exposed to CUR and in control group. Image Master 2D Platinum 6.0 software was used to analyse the differentially expressed proteins in two groups,and the matrix assisted laser desorption/ionization-time of flight-mass spectrometry ( MALDI-TOF-MS ) was used to identify them. Western blot was used to verify them. Results Among the differentially expressed proteins in the two groups, CK1 and ERpl9 were upregulated markedly; two proteins had been identified by MALDI-TOF-MS and western blot. Conclusion Up-regulation of CK1 and ERpl9 may be one mecha- nism of antioxidant and anti-tumor effects of CUR.
出处 《中国药理学通报》 CAS CSCD 北大核心 2013年第5期700-703,共4页 Chinese Pharmacological Bulletin
基金 浙江省自然科学基金资助项目(No Y2090891)
关键词 姜黄素 L-02细胞 蛋白质组 双向凝胶电泳 角蛋白1 内质网蛋白19 curcumin L-02 cell line proteome two-dimensional gel electrophoresis CK1 ERpl9
  • 相关文献

参考文献7

二级参考文献50

共引文献164

同被引文献14

  • 1Bhattacharya B S,Sweby P K,Minihane A M,et al.A mathematical model of the sterol regulatory element binding protein 2 cholesterol biosynthesis pathway[J].J Theor Biol,2014,349:150-62.
  • 2Zelcer N,Hong C,Boyadjian R,et al.LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor[J].Science,2009,325(5936):100-4.
  • 3Watanabe Y,Suzuki S,Nishimura H,et al.Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies:an observational study in Japan[J].Medicine,2015,94(4):e416.
  • 4Nakagami H,Koriyama H,Morishita R.Therapeutic vaccines for hypertension and dyslipidemia[J].Int Heart J,2014,55(2):96-100.
  • 5Miao J,Haas J T,Manthena P,et al.Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins[J].J Lipid Res,2014,55(4):659-67.
  • 6Tai M H,Chen P K,Chen P Y,et al.Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells[J].Mol Nutr Food Res,2014,58(11):2133-45.
  • 7Kohno T.Report of the american heart association(AHA)scientific sessions 2014[J].Chicago Circ J,2015,79(1):34-40.
  • 8Dubuc G,Chamberland A,Wassef H,et al.Statins upregulate PCSK9,the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia[J].Arterioscler Thromb Vasc Biol,2004,24(8):1454-9.
  • 9Desai N R,Giugliano R P,Zhou J,et al.AMG 145,a monoclonal antibody against PCSK9,facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients:an analysis from the LAPLACE-TIMI 57 trial(LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57)[J].J Am Coll Cardiol,2014,63(5):430-3.
  • 10Dou X,Fan C,Wo L,et al.Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells[J].Planta Med,2008,74(11):1374-9.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部